|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,509.00 JPY | +0.40% |
|
+1.64% | +1.49% |
| 01-21 | Oasis Submits Shareholder Proposals to Kobayashi Pharmaceutical | CI |
| 01-20 | Oasis urges Kobayashi Pharma shareholders to vote against re-nomination of Akihiro Kobayashi and Yoshiro Katae | RE |
| Capitalization | 408B 2.58B 2.19B 2.04B 1.91B 3.56B 236B 3.77B 23.25B 9.21B 111B 9.66B 9.46B | P/E ratio 2025 * |
35.8x | P/E ratio 2026 * | 28.8x |
|---|---|---|---|---|---|
| Enterprise value | 348B 2.2B 1.87B 1.74B 1.63B 3.03B 201B 3.22B 19.84B 7.86B 95.12B 8.24B 8.08B | EV / Sales 2025 * |
2.11x | EV / Sales 2026 * | 2.02x |
| Free-Float |
60.58% | Yield 2025 * |
1.89% | Yield 2026 * | 1.93% |
| 1 day | +0.40% | ||
| 1 week | +1.64% | ||
| Current month | +1.49% | ||
| 1 month | +3.98% | ||
| 3 months | +3.71% | ||
| 6 months | +4.54% | ||
| Current year | +1.49% |
| 1 week | 5,323 |  | 5,544 |
| 1 month | 5,269 | | 5,555 |
| Current year | 5,323 | | 5,555 |
| 1 year | 4,850 | | 5,925 |
| 3 years | 4,700 | | 9,410 |
| 5 years | 4,700 | | 12,040 |
| 10 years | 4,205 | | 13,120 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 54 | 31/05/2013 | |
Noriaki Hirao
IRC | Investor Relations Contact | - | - |
Kenji Kohori
SAM | Sales & Marketing | 71 | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 54 | 31/05/2004 | |
Kunio Ito
BRD | Director/Board Member | 74 | 31/05/2013 |
Kaori Sasaki
BRD | Director/Board Member | 66 | 31/05/2016 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +7.46% | 1.19% | 7 M€ | |
| +5.11% | 0.21% | 12 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.40% | +1.64% | -3.54% | -39.66% | 2.58B | |
| +2.65% | +3.66% | -8.99% | +4.87% | 350B | |
| +0.56% | +1.81% | -6.23% | +4.95% | 144B | |
| +1.27% | +1.74% | -1.99% | +13.75% | 69.17B | |
| +1.43% | +2.73% | +4.45% | -6.61% | 67.46B | |
| +1.37% | +3.32% | +49.92% | -55.34% | 43.06B | |
| +2.13% | +2.84% | -14.46% | - | 34.01B | |
| -0.66% | -0.12% | -21.98% | -12.03% | 25.39B | |
| +0.28% | -7.02% | -9.29% | -10.19% | 19.02B | |
| -0.13% | +0.61% | +8.66% | +34.26% | 13.92B | |
| Average | +0.94% | +0.90% | -0.34% | -7.33% | 76.88B | |
| Weighted average by Cap. | +1.72% | +2.29% | -3.70% | +0.57% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 165B 1.04B 888M 824M 773M 1.44B 95.53B 1.53B 9.41B 3.73B 45.13B 3.91B 3.83B | 173B 1.09B 931M 865M 811M 1.51B 100B 1.6B 9.87B 3.91B 47.33B 4.1B 4.02B |
| Net income | 11.4B 71.98M 61.26M 56.89M 53.34M 99.33M 6.59B 105M 650M 257M 3.11B 270M 264M | 13.92B 87.89M 74.8M 69.47M 65.14M 121M 8.05B 129M 793M 314M 3.8B 330M 323M |
| Net Debt | -59.81B -378M -322M -299M -280M -521M -34.6B -553M -3.41B -1.35B -16.35B -1.42B -1.39B | -58.48B -369M -314M -292M -274M -510M -33.83B -540M -3.33B -1.32B -15.98B -1.39B -1.36B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/01/26 | 5,509.00 ¥ | +0.40% | 173,300 |
| 22/01/26 | 5,487.00 ¥ | +0.77% | 211,500 |
| 21/01/26 | 5,445.00 ¥ | -0.86% | 163,500 |
| 20/01/26 | 5,492.00 ¥ | +0.42% | 214,300 |
| 19/01/26 | 5,469.00 ¥ | +0.90% | 291,900 |
Delayed Quote Japan Exchange, January 23, 2026 at 06:30 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4967 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition